Published in EMBO J on January 01, 1982
Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: three-dimensional organization and protein composition. J Cell Biol (1984) 3.48
Introducing intermediate filaments: from discovery to disease. J Clin Invest (2009) 1.96
Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading. J Cell Biol (1987) 1.92
Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol (1990) 1.88
The complement of desmosomal plaque proteins in different cell types. J Cell Biol (1985) 1.76
Insights into the dynamic properties of keratin intermediate filaments in living epithelial cells. J Cell Biol (2001) 1.66
Steady state dynamics of intermediate filament networks. J Cell Biol (1992) 1.59
Differential control of cytokeratins and vimentin synthesis by cell-cell contact and cell spreading in cultured epithelial cells. J Cell Biol (1984) 1.57
Phosphorylation of desmin in vitro inhibits formation of intermediate filaments; identification of three kinase A sites in the aminoterminal head domain. EMBO J (1988) 1.54
The organizational fate of intermediate filament networks in two epithelial cell types during mitosis. J Cell Biol (1985) 1.38
Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis. Mol Biol Cell (2003) 1.38
Intermediate filaments formed de novo from tail-less cytokeratins in the cytoplasm and in the nucleus. J Cell Biol (1991) 1.37
Monoclonal cytokeratin antibodies that distinguish simple from stratified squamous epithelia: characterization on human tissues. EMBO J (1982) 1.37
Phosphorylation and disassembly of intermediate filaments in mitotic cells. Proc Natl Acad Sci U S A (1989) 1.37
Phosphorylation of keratin and vimentin polypeptides in normal and transformed mitotic human epithelial amnion cells: behavior of keratin and vimentin filaments during mitosis. J Cell Biol (1983) 1.35
Cytokeratin and neurofilament in lung carcinomas. Am J Pathol (1984) 1.29
Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol (1989) 1.28
Keratin incorporation into intermediate filament networks is a rapid process. J Cell Biol (1991) 1.27
Change of cytokeratin filament organization during the cell cycle: selective masking of an immunologic determinant in interphase PtK2 cells. J Cell Biol (1983) 1.19
Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex. Arch Dermatol Res (1989) 1.15
Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J Virol (1994) 1.12
Enhancer elements directing cell-type-specific expression of cytokeratin genes and changes of the epithelial cytoskeleton by transfections of hybrid cytokeratin genes. EMBO J (1989) 1.10
Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. Mol Biol Cell (2002) 1.09
Dynamics of keratin assembly: exogenous type I keratin rapidly associates with type II keratin in vivo. J Cell Biol (1993) 1.04
Two different protein kinases act on a different time schedule as glial filament kinases during mitosis. EMBO J (1992) 1.02
Insights into the mechanical properties of epithelial cells: the effects of shear stress on the assembly and remodeling of keratin intermediate filaments. FASEB J (2009) 1.00
Do cells show an inverse locomotory response to fibronectin and laminin substrates? EMBO J (1985) 1.00
Cytokeratin phosphorylation, cytokeratin filament severing and the solubilization of the maternal mRNA Vg1. J Cell Biol (1991) 0.95
GCP6 binds to intermediate filaments: a novel function of keratins in the organization of microtubules in epithelial cells. Mol Biol Cell (2006) 0.92
Differential extraction of keratin subunits and filaments from normal human epidermis. J Cell Biol (1990) 0.84
Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells. Proc Natl Acad Sci U S A (1983) 0.83
Cell cycle-dependent changes in the organization of an intermediate filament-associated protein: correlation with phosphorylation by p34cdc2. Proc Natl Acad Sci U S A (1992) 0.82
Host cell factors controlling vimentin organization in the Xenopus oocyte. J Cell Biol (1992) 0.80
Intestinal cell barrier function in vitro is severely compromised by keratin 8 and 18 mutations identified in patients with inflammatory bowel disease. PLoS One (2014) 0.79
Keratin 8 is required for the maintenance of architectural structure in thymus epithelium. PLoS One (2013) 0.76
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst (1973) 10.64
The nuclear envelope lamina is reversibly depolymerized during mitosis. Cell (1980) 7.67
BIOLOGIC CHARACTERISTICS OF A CONTINUOUS KIDNEY CELL LINE DERIVED FROM THE AFRICAN GREEN MONKEY. J Immunol (1963) 7.43
INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS. Proc Natl Acad Sci U S A (1964) 5.60
10 nm filaments in normal and transformed cells. Cell (1978) 4.77
Self-assembly of bovine epidermal keratin filaments in vitro. J Mol Biol (1976) 4.43
Regulation of protein synthesis in mammalian cells. II. Inhibition of protein synthesis at the level of initiation during mitosis. J Mol Biol (1970) 3.98
Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J Cell Biol (1982) 3.80
Culture characteristics of four permanent lines of human cancer cells. Cancer Res (1955) 3.69
Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer (1979) 3.37
Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol (1981) 3.37
Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Eur J Biochem (1978) 2.86
Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer (1973) 2.83
Controlled production of proliferating somatic cell hybrids. J Cell Biol (1970) 2.78
Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (1976) 2.65
Epithelial cell cultures from normal glandular tissue of mice. J Natl Cancer Inst (1974) 2.32
Cultivation of human breast carcinomas. J Natl Cancer Inst (1958) 2.19
Architecture and polypeptide composition of HeLa cytoskeletons. Modification of cytoarchitectural polypeptides during mitosis. J Mol Biol (1982) 2.13
Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst (1977) 2.07
Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res (1976) 1.97
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer (1972) 1.86
Effects of SV40 transformation on the cytoskeleton and behavioural properties of human keratinocytes. Cell Differ (1982) 1.81
Intermediate filaments of the vimentin-type and the cytokeratin-type are distributed differently during mitosis. Exp Cell Res (1980) 1.66
Endocytosis and chloroquine accumulation during the cell cycle of hepatoma cells in culture. J Cell Biol (1979) 1.45
Ten-nanometer filaments and mitosis: maintenance of structural continuity in dividing endothelial cells. Proc Natl Acad Sci U S A (1979) 1.44
Reorganization of arrays of prekeratin filaments during mitosis. Immunofluorescence microscopy with multiclonal and monoclonal prekeratin antibodies. Exp Cell Res (1981) 1.43
An alteration in the phosphorylation of vimentin-type intermediate filaments is associated with mitosis in cultured mammalian cells. Cell (1982) 1.35
The occurrence and possible role of 80-100 A filaments in PtKl cells. Exp Cell Res (1975) 1.34
Aortic smooth muscle cells contain vimentin instead of desmin. Proc Natl Acad Sci U S A (1981) 1.31
Intermediate filaments: a family of homologous structures. J Muscle Res Cell Motil (1981) 1.27
Microviscosity modulation during the cell cycle of neuroblastoma cells. Proc Natl Acad Sci U S A (1977) 1.26
Properties of Ca2+-activated protease specific for the intermediate-sized filament protein vimentin in Ehrlich-ascites-tumour cells. Eur J Biochem (1981) 1.25
Establishment and characterization of SV40-transformed human breast epithelial cell lines. Cancer Res (1982) 1.20
ESTABLISHMENT AND CHARACTERISTICS OF CELL STRAINS FROM SOME EPITHELIAL TUMORS OF HUMAN ORIGIN. J Natl Cancer Inst (1963) 1.20
Stages in neoplastic transformation of adult epithelial cells by 7,12-dimethylbenz(a)anthracene in vitro. Cancer Res (1977) 1.19
The synthesis of ninety proteins including actin throughout the HeLa cell cycle. J Cell Biol (1978) 1.17
Use of antibodies to intermediate filaments in the characterization of human tumors. Cold Spring Harb Symp Quant Biol (1982) 1.16
Chromosomes in a marsupial (Potorous tridactylis) tissue culture. Nature (1962) 1.15
Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor. Cancer Res (1976) 1.13
Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerve. Brain Res (1979) 1.08
Cell surface distribution of fibronectin in cultures of fibroblasts and bladder derived epithelium: SEM-immunogold localization compared to immunoperoxidase and immunofluorescence.. J Microsc (1981) 1.01
Epithelial tonofilaments: investigating their form and function using monoclonal antibodies. Cold Spring Harb Symp Quant Biol (1982) 1.00
Contrast between the environmental pH dependencies of prophasing and nuclear membrane formation in interphase-metaphase cells. J Cell Biol (1973) 0.86
Increased phosphorylation rate of intermediate filaments during mitotic arrest. Exp Cell Res (1981) 0.84
Structural transformation of epidermal tonofilaments upon cold treatment. Exp Cell Res (1979) 0.81
Duration of mitosis and separate mitotic phases compared to nuclear DNA content in erythroblasts of four vertebrates;. Cell Tissue Kinet (1975) 0.79
Changes in microtubule phosphorylation during cell cycle of HeLa cells. Proc Natl Acad Sci U S A (1975) 0.79
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Effects of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials (1999) 4.32
Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J Cell Biol (1982) 3.80
Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol (1985) 3.77
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res (2001) 3.01
N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem (1999) 2.76
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69
Cell-cell interaction and polarity of epithelial cells: specific perturbation using a monoclonal antibody. Cell (1983) 2.56
Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest (1994) 2.13
Keratin antigens in differentiating skin. Ann N Y Acad Sci (1985) 2.10
Antibody markers of basal cells in complex epithelia. J Cell Sci (1990) 2.08
Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci (1989) 2.07
Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst (1985) 2.03
Nanoscale topography of the basement membrane underlying the corneal epithelium of the rhesus macaque. Cell Tissue Res (2000) 2.03
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest (1999) 2.03
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med (2001) 2.00
Intermediate filaments in disease. Curr Opin Cell Biol (1995) 1.98
Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res (1986) 1.94
Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading. J Cell Biol (1987) 1.92
Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol (1991) 1.88
Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J Invest Dermatol (1991) 1.87
Immune response to Campylobacter pyloridis. Lancet (1985) 1.86
Nanoscale topography of the corneal epithelial basement membrane and Descemet's membrane of the human. Cornea (2000) 1.84
Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet (1995) 1.83
Effects of SV40 transformation on the cytoskeleton and behavioural properties of human keratinocytes. Cell Differ (1982) 1.81
Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78
Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75
An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res (1999) 1.74
Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet (1997) 1.68
Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J Cell Biol (1999) 1.64
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol (1989) 1.61
Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: specific domain functions in keratin stabilization and filament formation. Cell (1990) 1.59
Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol (1985) 1.58
Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol (1990) 1.53
Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature (1983) 1.52
Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet (1984) 1.51
A functional "knockout" of human keratin 14. Genes Dev (1994) 1.48
Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol (1989) 1.46
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Morphology, behavior, and interaction of cultured epithelial cells after the antibody-induced disruption of keratin filament organization. J Cell Biol (1983) 1.41
Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer (1997) 1.40
The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes. Clin Exp Immunol (1985) 1.39
Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J Biol Chem (1999) 1.38
Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol (1987) 1.33
Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol (1999) 1.32
Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol (1997) 1.32
Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. Dev Biol (1988) 1.32
Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B. Oncogene (1999) 1.30
Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol (1999) 1.30
Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology (2004) 1.28
Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor? Biochem J (1998) 1.27
Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin. J Biol Chem (1991) 1.26
Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem (2000) 1.22
An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci (1995) 1.21
Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol (1998) 1.21
Establishment and characterization of SV40-transformed human breast epithelial cell lines. Cancer Res (1982) 1.20
Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. Differentiation (1991) 1.20
Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br J Dermatol (2003) 1.19
Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies. J Clin Pathol (1984) 1.17
Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol (2011) 1.17
Detection of the p53 response in zebrafish embryos using new monoclonal antibodies. Oncogene (2007) 1.17
Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci (1986) 1.17
ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods (1987) 1.16
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res (1997) 1.14
Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. J Cell Sci (1995) 1.14
Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J Cell Sci (1995) 1.13
The development of epithelial phenotypes in the human fetal and infant breast. J Pathol (1998) 1.13
A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet (1995) 1.12
Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am J Pathol (1985) 1.12
Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol (1991) 1.12
cDNA cloning, expression, and assembly characteristics of mouse keratin 16. J Biol Chem (1998) 1.12
Expression of individual lamins in basal cell carcinomas of the skin. Br J Cancer (2001) 1.11
Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res (2001) 1.10
Specialized keratin expression pattern in human ridged skin as an adaptation to high physical stress. Br J Dermatol (1998) 1.10
Reconstitution of human urothelium from monolayer cultures. J Urol (1997) 1.10
Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins. Cell (1985) 1.09
Expression of the LFA-1 beta 2 integrin (CD11a/CD18) and ICAM-1 (CD54) in normal and coeliac small bowel mucosa. Scand J Immunol (1991) 1.08
Cell cycle changes in A-type lamin associations detected in human dermal fibroblasts using monoclonal antibodies. Chromosome Res (1997) 1.06
Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation. Oncogene (1998) 1.06
Keratin expression in basal cell carcinomas. Br J Dermatol (1992) 1.06
Urothelial tissue culture for bladder reconstruction: an experimental study. J Urol (1993) 1.05
A rapid antibody assay system for screening hybridoma cultures. J Immunol Methods (1981) 1.04
Patterns of cytokeratin expression in human gingival epithelia. J Periodontal Res (1991) 1.03
Patterns of keratin-expression in rests of Malassez and periapical lesions. J Oral Pathol (1988) 1.03
Lack of a serologic response to an E1B protein of adenovirus 12 in coeliac disease. Scand J Gastroenterol (1989) 1.03
Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut (1995) 1.03
Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol (1998) 1.01
Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells. J Cell Sci (1997) 1.01
A review of the colloidal gold marker system. Scan Electron Microsc (1980) 1.01
Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet (1984) 1.01
Cell surface distribution of fibronectin in cultures of fibroblasts and bladder derived epithelium: SEM-immunogold localization compared to immunoperoxidase and immunofluorescence.. J Microsc (1981) 1.01
Expression of the common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol (1985) 1.01
Epithelial tonofilaments: investigating their form and function using monoclonal antibodies. Cold Spring Harb Symp Quant Biol (1982) 1.00
An immunocytochemical study of fetal cells at the maternal-placental interface using monoclonal antibodies to keratins, vimentin and desmin. Cell Tissue Res (1986) 1.00